Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.
Press releases published on September 21, 2025
DoctorShield collaborates with Association of Malaysian Optometrists
MALAYSIA, September 22, 2025 /EINPresswire.com/ -- Kuala Lumpur, Malaysia JA Assure Sdn Bhd (“JA”) and the Association of Malaysian Optometrists (“AMO”) have entered into an agreement to advance medico-legal awareness among optometrists and to …
Kansas Carradine and Daughters Deliver Powerful Performance for Lassos with Love Fundraiser At Five Star Equestrian
Horses take center stage, reminding guests of the healing power of connection and presence PLEASANTON, CA, UNITED STATES, September 21, 2025 /EINPresswire.com/ -- Connected Horse opened its 2025 Lassos with Love fundraiser with a moving equestrian …
WHO Disenfranchises the Public from Tobacco Control Conference as Registration Barriers Reach "Insane" Levels
MANILA, Philippines, Sept. 22, 2025 (GLOBE NEWSWIRE) -- The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) today condemned the World Health Organisation's Framework Convention on Tobacco Control (WHO FCTC) for erecting deliberate …
Rashawn “RJ” Blakney Crowned MVP of the V-League All-Star Game
Rashawn “RJ” Blakney Crowned MVP of the V-League All-Star Game. Rising Star’s Journey Reflects the Grit, Ambition, and Opportunity at the Heart of the V-League BALTIMORE , NJ, UNITED STATES, September 20, 2025 /EINPresswire.com/ -- The V-League, America …
Global Impact Wellness Group Hosts 'Global Day' with the Baltimore Ravens
Global Impact Wellness Group Hosts “Global Day” with the Baltimore Ravens to Champion Mental Health, Substance Abuse Treatment, and Suicide Prevention BALTIMORE, MD, UNITED STATES, September 20, 2025 /EINPresswire.com/ -- Global Impact Wellness Group, a …
KFSHRC Advances Radiopharmaceuticals for Cancer Care
ٍRIYADH, SAUDI ARABIA, September 20, 2025 /EINPresswire.com/ -- King Faisal Specialist Hospital and Research Centre (KFSHRC) is advancing the use of radiopharmaceuticals in Saudi Arabia, producing vital compounds that support cancer diagnostics and …
Today Marks International Akathisia Awareness Day
MISSD's New Public Health Video Raises Awareness of this Medication-Induced Disorder Linked to Suicide CHICAGO, IL, UNITED STATES, September 20, 2025 /EINPresswire.com/ -- The Medication-Induced Suicide Prevention and Education Foundation in Memory of …
Doctors Against Genocide Hosts Second Annual Conference in Ann Arbor
Conference Theme: Genocide and Mass Atrocities as a Global Public Health Emergency ANN ARBOR, MI, UNITED STATES, September 20, 2025 /EINPresswire.com/ -- Doctors Against Genocide (DAG) will convene its Second Annual Conference in Ann Arbor, Michigan, …
Dr. Luis F. Garcia Launches Biomagnetism Online Training Program for Health and Wellness Professionals
Dr. Luis F. Garcia has launched a 25-hour Biomagnetism online training program offering modular lessons, reference tools, and legal/ethical guidance. NORTH BRUNSWICK, NJ, UNITED STATES, September 21, 2025 /EINPresswire.com/ -- Dr. Luis F. Garcia has …
Consejo Nacional de Drogas Dominicano y Mundo Libre de Drogas Internacional Conversatorio con Athletas Jovenes
El Consejo Nacional de Drogas Republica Dominicana y Mundo Libre de Drogas Internacional Conversan Con Athletas Jovenes Sobre El Peligro de Las Drogas Ilicitas SANTO DOMINGO, DISTRITO NACIONAL, DOMINICAN REPUBLIC, September 20, 2025 /EINPresswire.com/ …
Patronato Nacional de Seguridad Ciudadana y Fundación Un Mundo Libre de Drogas Firman Acuerdo en República Dominicana
Patronato Nacional de Seguridad Ciudadana y Fundación por Un Mundo Libre de Drogas, Capitulo de las Americas Firman Acuerdo -Santo Domingo, República Dominicana SANTO DOMINGO, DISTRITO NACIONAL, DOMINICAN REPUBLIC, September 20, 2025 /EINPresswire.com/ …
Patients Taking AUSTEDO XR® (deutetrabenazine) extended-release tablets Reported Symptom Improvement and High Satisfaction
Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94% reported movement improvement once treated with AUSTEDO XR® (deutetrabenazine) extended-release tablets Patients reported high satisfaction (>89%) with AUSTEDO XR, with 96% …
New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-'749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed
Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with olanzapine LAI (TEV-'749) and its long-term systemic safety profile was consistent with other olanzapine …